Establishment Labs Holdings Inc.
Establishment Labs Holdings Inc. (ESTA) Financial Performance & Income Statement Overview
Analyze Establishment Labs Holdings Inc. (ESTA) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.
Establishment Labs Holdings Inc. (ESTA) Income Statement & Financial Overview
Explore comprehensive income reports for Establishment Labs Holdings Inc. ESTA, broken down by year and quarter.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $41.38M | $44.51M | $40.23M | $44.12M |
| Cost of Revenue | $13.57M | $14.02M | $14.51M | $15.18M |
| Gross Profit | $27.81M | $30.49M | $25.72M | $28.94M |
| Gross Profit Ratio | $0.67 | $0.68 | $0.64 | $0.66 |
| R&D Expenses | $5.05M | $5.14M | $4.80M | $5.49M |
| SG&A Expenses | $39.70M | $44.02M | $34.05M | $32.79M |
| Operating Expenses | $44.75M | $49.16M | $38.86M | $38.28M |
| Total Costs & Expenses | $58.32M | $63.18M | $53.37M | $53.46M |
| Interest Income | $250000.00 | $199000.00 | $234000.00 | $556000.00 |
| Interest Expense | $5.85M | $5.95M | $5.31M | $5.19M |
| Depreciation & Amortization | $0.00 | $2.39M | $2.19M | $1.58M |
| EBITDA | -$16.95M | -$27.60M | -$8.67M | -$9.98M |
| EBITDA Ratio | -$0.41 | -$0.62 | -$0.22 | -$0.23 |
| Operating Income | -$16.95M | -$18.67M | -$13.14M | -$9.34M |
| Operating Income Ratio | -$0.41 | -$0.42 | -$0.33 | -$0.21 |
| Other Income/Expenses (Net) | -$2.85M | -$17.27M | -$3.03M | -$7.41M |
| Income Before Tax | -$19.80M | -$35.94M | -$16.17M | -$16.75M |
| Income Before Tax Ratio | -$0.48 | -$0.81 | -$0.40 | -$0.38 |
| Income Tax Expense | -$914000.00 | -$1.41M | $510000.00 | $428000.00 |
| Net Income | -$20.71M | -$34.53M | -$16.68M | -$17.18M |
| Net Income Ratio | -$0.50 | -$0.78 | -$0.41 | -$0.39 |
| EPS | -$0.70 | -$1.19 | -$0.60 | -$0.62 |
| Diluted EPS | -$0.70 | -$1.19 | -$0.60 | -$0.62 |
| Weighted Avg Shares Outstanding | $29.48M | $28.94M | $27.91M | $27.91M |
| Weighted Avg Shares Outstanding (Diluted) | $29.48M | $28.94M | $27.91M | $27.91M |
The company's financials show resilient growth, with revenue advancing from $44.12M in Q2 2024 to $41.38M in Q1 2025. Gross profit remained healthy with margins at 67% in Q1 2025 compared to 66% in Q2 2024. Operating income hit -$16.95M last quarter, sustaining a consistent -41% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at -$16.95M. Net income rose to -$20.71M, while earnings per share reached -$0.70. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan